Scripps Mericos Eye Institute - La Jolla, California 92037

Scripps Mericos Eye Institute is categorized under Ophthalmologists in La Jolla, CA .

Business Name: Scripps Mericos Eye Institute
Contact Person: Sally Super, Office Manager
Address: 9888 Genesee Avenue, La Jolla, California 92037
Phone Number: (858) 626-4444
Website Address: scripps.org
Annual Revenue (USD): $1.000.000 to $2.499.999
Founding Year: 1984
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Ophthalmologists
SIC Code: 8011
NAICS Code: 6214930
Share This Business:
Related Businesses: The Eye Center LLC - La Jolla, CA 92037
Bethel Kelly J MD - La Jolla, CA 92037
Douglas G Boyden Md - La Jolla, CA 92037
Eye Care of LA Jolla - La Jolla, CA 92037
Retina Consultants San Diego - La Jolla, CA 92037
Envision Eye A Professional Medical Corporation - La Jolla, CA 92037
San Diego Vitreoretinal Association Inc - La Jolla, CA 92037
William L Basuk Md - La Jolla, CA 92037
Alan C Western MD - La Jolla, CA 92037
San Diego Vitreoretinal Assoc - La Jolla, CA 92037
Advanced Ophthalmology Institute - La Jolla, CA 92037
Murphy Eye Center - La Jolla, CA 92037
Vida Lee Md Facs - La Jolla, CA 92037
Robert W Herbst Md - La Jolla, CA 92037

The company Scripps Mericos Eye Institute provides B2C services in the form of Ophthalmologists from its branch in California. 1 to 4 employees work for Scripps Mericos Eye Institute, and the business now earns $1.000.000 to $2.499.999 per annum.

Scripps Mericos Eye Institute was launched in 1984 and is classified under SIC code and category 8011 , and NAICS number and grouping 6214930 . To contact Scripps Mericos Eye Institute, please call Sally Super, Office Manager with the phone number (858) 626-4444 or visit its branch at 9888 Genesee Avenue in La Jolla, California 92037.

The location of the branch can also be found using the coordinates 32.884678,-117.22242. Read more details about this business on the webpage scripps.org or follow the company’s social media accounts, on Twitter and on Facebook.